GB0207436D0 - Novel compounds - Google Patents
Novel compoundsInfo
- Publication number
- GB0207436D0 GB0207436D0 GBGB0207436.7A GB0207436A GB0207436D0 GB 0207436 D0 GB0207436 D0 GB 0207436D0 GB 0207436 A GB0207436 A GB 0207436A GB 0207436 D0 GB0207436 D0 GB 0207436D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- novel compounds
- novel
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0207436.7A GB0207436D0 (en) | 2002-03-28 | 2002-03-28 | Novel compounds |
| TW092106769A TW200400824A (en) | 2002-03-28 | 2003-03-26 | Novel compounds |
| AU2003226759A AU2003226759A1 (en) | 2002-03-28 | 2003-03-27 | Morpholine derivatives substituted at the 2-position by an arylalkylurea group for use as ccr-3 antagonists in the treatment of inflammatory conditions |
| ARP030101084A AR039172A1 (en) | 2002-03-28 | 2003-03-27 | MORFOLINA DERIVATIVES, CCR3 ANTAGONISTS. |
| PCT/EP2003/003340 WO2003082292A1 (en) | 2002-03-28 | 2003-03-27 | Morpholine derivatives substituted at the 2-position by an arylalkylurea group for use as ccr-3 antagonists in the treatment of inflammatory conditions |
| EP03745296A EP1487455A1 (en) | 2002-03-28 | 2003-03-27 | Morpholine derivatives substituted at the 2-position by an arylalkylurea group for use as ccr-3 antagonists in the treatment of inflammatory conditions |
| JP2003579829A JP2005526807A (en) | 2002-03-28 | 2003-03-27 | Morpholine derivative substituted at the 2-position by an arylalkylurea group for use as a CCR-3 antagonist in the treatment of inflammatory conditions |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0207436.7A GB0207436D0 (en) | 2002-03-28 | 2002-03-28 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB0207436D0 true GB0207436D0 (en) | 2002-05-08 |
Family
ID=9933988
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB0207436.7A Ceased GB0207436D0 (en) | 2002-03-28 | 2002-03-28 | Novel compounds |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1487455A1 (en) |
| JP (1) | JP2005526807A (en) |
| AR (1) | AR039172A1 (en) |
| AU (1) | AU2003226759A1 (en) |
| GB (1) | GB0207436D0 (en) |
| TW (1) | TW200400824A (en) |
| WO (1) | WO2003082292A1 (en) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR028948A1 (en) | 2000-06-20 | 2003-05-28 | Astrazeneca Ab | NEW COMPOUNDS |
| MY149038A (en) | 2004-05-26 | 2013-07-15 | Eisai R&D Man Co Ltd | Cinnamide compound |
| JP4970946B2 (en) | 2004-09-08 | 2012-07-11 | 田辺三菱製薬株式会社 | Morpholine compounds |
| KR20070083781A (en) | 2004-10-26 | 2007-08-24 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | Amorphous object of cinnamide compound |
| BRPI0615064A2 (en) * | 2005-08-26 | 2011-05-03 | Astrazeneca Ab | combination of compounds that can be used to treat respiratory diseases, especially chronic obstructive pulmonary disease (dpoc) and asthma |
| TW200744612A (en) * | 2005-08-26 | 2007-12-16 | Astrazeneca Ab | New combination |
| TWI370130B (en) | 2005-11-24 | 2012-08-11 | Eisai R&D Man Co Ltd | Two cyclic cinnamide compound |
| BRPI0618814A2 (en) | 2005-11-24 | 2014-04-29 | Eisai R&D Man Co Ltd | COMPOUND OR PHARMACOLOGICALLY ACCEPTABLE SALT OF THE SAME, AND PHARMACEUTICAL AGENT |
| TWI378091B (en) | 2006-03-09 | 2012-12-01 | Eisai R&D Man Co Ltd | Multi-cyclic cinnamide derivatives |
| AU2007252643A1 (en) * | 2006-05-19 | 2007-11-29 | Eisai R & D Management Co., Ltd. | Urea type cinnamide derivative |
| AR062095A1 (en) | 2006-07-28 | 2008-10-15 | Eisai R&D Man Co Ltd | CINAMIDE COMPOUND PROFARMACO |
| WO2008103126A1 (en) * | 2007-02-23 | 2008-08-28 | Astrazeneca Ab | Novel combination of compounds to be used in the treatment of airway diseases, especially chronic obstructive pulmonary disease (copd) and asthma |
| US20080207900A1 (en) | 2007-02-28 | 2008-08-28 | Teiji Kimura | Two cyclic oxomorphorin derivatives |
| US7935815B2 (en) | 2007-08-31 | 2011-05-03 | Eisai R&D Management Co., Ltd. | Imidazoyl pyridine compounds and salts thereof |
| CL2008002542A1 (en) | 2007-08-31 | 2009-01-02 | Eisai R&D Man Co Ltd | Imidazolyl pyridine derived compounds linked to a heterocycle via a vinyl, modulators of amyloid-beta activity; pharmaceutical composition comprising said compounds; and its use for the treatment of diseases such as Alzheimer's, dementia, Down syndrome or amyloidosis. |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995031431A1 (en) * | 1994-05-18 | 1995-11-23 | Nisshin Flour Milling Co., Ltd. | Novel diaminomethylidene derivative |
| HUP0104364A2 (en) * | 1998-11-20 | 2002-04-29 | F. Hoffmann-La Roche Ag. | Pyrrolidine derivatives-ccr-3 receptor antagonists |
| AU2001290146A1 (en) * | 2000-09-29 | 2002-04-08 | Glaxo Group Limited | Compounds useful in the treatment of inflammatory diseases |
-
2002
- 2002-03-28 GB GBGB0207436.7A patent/GB0207436D0/en not_active Ceased
-
2003
- 2003-03-26 TW TW092106769A patent/TW200400824A/en unknown
- 2003-03-27 AR ARP030101084A patent/AR039172A1/en unknown
- 2003-03-27 JP JP2003579829A patent/JP2005526807A/en active Pending
- 2003-03-27 AU AU2003226759A patent/AU2003226759A1/en not_active Abandoned
- 2003-03-27 WO PCT/EP2003/003340 patent/WO2003082292A1/en not_active Application Discontinuation
- 2003-03-27 EP EP03745296A patent/EP1487455A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003226759A1 (en) | 2003-10-13 |
| EP1487455A1 (en) | 2004-12-22 |
| JP2005526807A (en) | 2005-09-08 |
| WO2003082292A1 (en) | 2003-10-09 |
| TW200400824A (en) | 2004-01-16 |
| AR039172A1 (en) | 2005-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0202216D0 (en) | Novel compounds | |
| GB0202679D0 (en) | Novel compounds | |
| GB0206723D0 (en) | Novel compounds | |
| IL164047A0 (en) | Novel compounds | |
| GB0207436D0 (en) | Novel compounds | |
| GB0207249D0 (en) | Novel compounds | |
| GB0207246D0 (en) | Novel compounds | |
| GB0203299D0 (en) | Novel compounds | |
| GB0200025D0 (en) | Novel compounds | |
| GB0204252D0 (en) | Novel compounds | |
| GB0207443D0 (en) | Novel compounds | |
| GB0212357D0 (en) | Novel compounds | |
| GB0207278D0 (en) | Novel compounds | |
| GB0203901D0 (en) | Novel compounds | |
| GB0202219D0 (en) | Novel compounds | |
| GB0206197D0 (en) | Novel compounds | |
| GB0207281D0 (en) | Novel compounds | |
| GB0202442D0 (en) | Novel compounds | |
| GB0202636D0 (en) | Novel compounds | |
| GB0202637D0 (en) | Novel compounds | |
| GB0202140D0 (en) | Novel compounds | |
| GB0201357D0 (en) | Novel compounds | |
| GB0203300D0 (en) | Novel compounds | |
| GB0203301D0 (en) | Novel compounds | |
| GB0203363D0 (en) | Novel compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |